Literature DB >> 14530350

Evidence for naturally acquired T cell-mediated mucosal immunity to Neisseria meningitidis.

Victoria Davenport1, Terry Guthrie, Jamie Findlow, Ray Borrow, Neil A Williams, Robert S Heyderman.   

Abstract

Naturally acquired protective immunity against Neisseria meningitidis is thought to partially explain the disparity between the high levels of carriage in the human nasopharynx and the rare incidence of disease. To investigate this immunity to Neisseria meningitidis at the mucosal level, in vitro cellular responses to outer membrane vesicle preparations derived from this pathogen were examined using mononuclear cells from the palatine tonsils of adults and children. Characterization of these responses was achieved by depletion of CD45RA(+), CD45RO(+), and CD19(+) populations and outer membrane vesicles derived from isogenic mutants expressing different serosubtypes of the major outer membrane protein, porin A (PorA), no PorA and membrane preparations from a mutant with no LPS (LpxA(-)). The magnitude of cellular proliferative responses against the outer membrane vesicles were strongly associated with age and were largely T cell mediated, involving both CD45RO(+) and CD45RA(+) T cell phenotypes. Responses were not dependent on LPS but consisted of both PorA cross-specific and non-PorA-dependent responses. Cellular immunity against Neisseria meningitidis was found to be frequently associated with systemic IgG Abs but was not associated with serum bactericidal Abs. For the first time our results demonstrate an age-associated acquisition of mucosal T effector/memory cell responses to Neisseria meningitidis. This mucosal cellular immunity can be present in the absence of serum bactericidal Abs, a classical marker of protective immunity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14530350     DOI: 10.4049/jimmunol.171.8.4263

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Sterilizing immunity elicited by Neisseria meningitidis carriage shows broader protection than predicted by serum antibody cross-reactivity in CEACAM1-humanized mice.

Authors:  Kay O Johswich; Shannon E McCaw; Lea Strobel; Matthias Frosch; Scott D Gray-Owen
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  Cellular Immune Responses in Humans Induced by Two Serogroup B Meningococcal Outer Membrane Vesicle Vaccines Given Separately and in Combination.

Authors:  Fredrik Oftung; Gro Ellen Korsvold; Audun Aase; Lisbeth M Næss
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

3.  Meningococcal meningitis in two patients with primary antibody deficiency treated with replacement intravenous immunoglobulin.

Authors:  S Lear; E Eren; J Findlow; R Borrow; D Webster; S Jolles
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

4.  T-cell-stimulating protein A elicits immune responses during meningococcal carriage and human disease.

Authors:  Karen Robinson; Karl G Wooldridge; Damien B Wells; Amal Hasan; Ian Todd; Adrian Robins; Richard James; Dlawer A A Ala'Aldeen
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac.

Authors:  Jamie Findlow; Stephen Taylor; Audun Aase; Rachel Horton; Robert Heyderman; Jo Southern; Nick Andrews; Rita Barchha; Ewan Harrison; Ann Lowe; Emma Boxer; Charlotte Heaton; Paul Balmer; Ed Kaczmarski; Philipp Oster; Andrew Gorringe; Ray Borrow; Elizabeth Miller
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

6.  Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England.

Authors:  Caroline Trotter; Jamie Findlow; Paul Balmer; Ann Holland; Rita Barchha; Nick Hamer; Nick Andrews; Elizabeth Miller; Ray Borrow
Journal:  Clin Vaccine Immunol       Date:  2007-05-09

7.  Opa+ and Opa- isolates of Neisseria meningitidis and Neisseria gonorrhoeae induce sustained proliferative responses in human CD4+ T cells.

Authors:  Abdel-Rahman Youssef; Michiel van der Flier; Silvia Estevão; Nico G Hartwig; Peter van der Ley; Mumtaz Virji
Journal:  Infect Immun       Date:  2009-08-31       Impact factor: 3.441

Review 8.  How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines.

Authors:  R Gasparini; D Panatto; N L Bragazzi; P L Lai; A Bechini; M Levi; P Durando; D Amicizia
Journal:  J Immunol Res       Date:  2015-08-17       Impact factor: 4.818

9.  Comparative Proteomics Analysis of Two Strains of Neisseria meningitidis Serogroup B and Neisseria lactamica.

Authors:  Raheleh Sheikhi; Mansour Amin; Maryam Hamidinia; Mohammad Ali Assarehzadegan; Soodabeh Rostami; Zahra Mojtahedi
Journal:  Jundishapur J Microbiol       Date:  2015-11-14       Impact factor: 0.747

10.  Identification of meningococcal genes necessary for colonization of human upper airway tissue.

Authors:  Rachel M Exley; Richard Sim; Linda Goodwin; Megan Winterbotham; Muriel C Schneider; Robert C Read; Christoph M Tang
Journal:  Infect Immun       Date:  2008-10-20       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.